NCT00237289View on ClinicalTrials.gov

Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient Setting

PHASE3CompletedINTERVENTIONAL
Enrollment

287

Participants

Timeline

Start Date

October 31, 2001

Study Completion Date

October 31, 2003

Conditions
Bipolar Disorder
Interventions
DRUG

topiramate

All Listed Sponsors
lead

Ortho-McNeil Neurologics, Inc.

INDUSTRY

NCT00237289 - Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient Setting | Biotech Hunter | Biotech Hunter